Back
Givaudan SA Vs. SpringWorks Therapeutics Industry Stock Comparison
Buy
83
GVDNY
Givaudan SA
Last Price:
$98.03
Seasonality Move:
4.23%
Sell
44
SWTX
SpringWorks Therapeutics
Last Price:
$46.23
Seasonality Move:
6.26%
Buy
83
Givaudan SA (GVDNY)
is a Buy
Is Givaudan SA a Buy, Sell or Hold?
-
The current Givaudan SA [GVDNY] share price is $97.60. The Score for GVDNY is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
-
GVDNY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
44
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy, Sell or Hold?
-
The current SpringWorks Therapeutics [SWTX] share price is $46.23. The Score for SWTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
SWTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GVDNY Stock Price Chart
What is Givaudan SA's stock price today?
-
The Givaudan SA share price today is $97.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GVDNY is experiencing slight buying pressure.
SWTX Stock Price Chart
What is SpringWorks Therapeutics's stock price today?
-
The SpringWorks Therapeutics share price today is $46.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SWTX is experiencing slight selling pressure.
GVDNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.09 | Buy |
Relative Strength Index (14 RSI): | 67.71 | Buy |
Chaikin Money Flow: | 2523 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86.82 - 94.76) | Buy |
Bollinger Bands (100): | (85.66 - 91.64) | Buy |
SWTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.51 | Buy |
Relative Strength Index (14 RSI): | 58.88 | Buy |
Chaikin Money Flow: | -822988 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.14 - 45.5) | Buy |
Bollinger Bands (100): | (35.98 - 50.56) | Buy |
GVDNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 94.65 | Buy |
20-day SMA: | 91.73 | Buy |
50-day SMA: | 90 | Buy |
200-day SMA: | 93.33 | Buy |
8-day EMA: | 95.11 | Buy |
20-day EMA: | 92.75 | Buy |
50-day EMA: | 90.62 | Buy |
200-day EMA: | 90.35 | Buy |
SWTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.25 | Buy |
20-day SMA: | 40.51 | Buy |
50-day SMA: | 46.51 | Sell |
200-day SMA: | 39.44 | Buy |
8-day EMA: | 44.83 | Buy |
20-day EMA: | 43.3 | Buy |
50-day EMA: | 43.84 | Buy |
200-day EMA: | 41.16 | Buy |
Givaudan SA Earnings Growth & GVDNY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $1.44 per share.
Givaudan SA Technical Analysis
Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
SpringWorks Therapeutics Technical Analysis
Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |